Franco Poletti - 15 Dec 2024 Form 4 Insider Report for LivaNova PLC (LIVN)

Role
President, Cardiopulmonary
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact
Issuer symbol
LIVN
Transactions as of
15 Dec 2024
Net transactions value
-$21,424
Form type
4
Filing time
17 Dec 2024, 17:23:02 UTC
Previous filing
17 Sep 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIVN Ordinary Shares Options Exercise $0 +967 +15% $0.000000 7,634 15 Dec 2024 Direct F1
transaction LIVN Ordinary Shares Tax liability $21,424 -416 -5.4% $51.50 7,218 15 Dec 2024 Direct F2
holding LIVN Ordinary Shares 219 15 Dec 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIVN Restricted Stock Units Options Exercise $0 -967 -50% $0.000000 967 15 Dec 2024 Ordinary Shares 967 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person had vested restricted stock units ("RSUs") settled in ordinary shares of LivaNova PLC (the "Company"), GBP 1.00 par value.
F2 Shares withheld to satisfy tax liability.
F3 Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the "Plan") and the award agreement.
F4 On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.